Page 115 - MI-2-3

Microbes & Immunity SARS-CoV-2 complementary classification

virus: A comprehensive review. Microorganisms. 150. Gruell H, Vanshylla K, Korenkov M, et al. SARS-CoV-2
2024;12(6):1035. Omicron sublineages exhibit distinct antibody escape
patterns. Cell Host Microbe. 2022;30(9):1231-1241.e6.
doi: 10.3390/microorganisms12061035
doi: 10.1016/j.chom.2022.07.002
142. Le Guillou-Guillemette H, Vallet S, Gaudy-Graffin C,
et al. Genetic diversity of the hepatitis C virus: Impact 151. Stefic K, Bouvin-Pley M, Braibant M, Barin F. Impact of
and issues in the antiviral therapy. World J Gastroenterol. HIV-1 diversity on its sensitivity to neutralization. Vaccines
2007;13(17):2416-2426. (Basel). 2019;7(3):74.
doi: 10.3748/wjg.v13.i17.2416 doi: 10.3390/vaccines7030074
143. Wu NC, Wilson IA. Influenza hemagglutinin structures 152. van de Sandt CE, Kreijtz JH, Rimmelzwaan GF. Evasion
and antibody recognition. Cold Spring Harb Perspect Med. of influenza A viruses from innate and adaptive immune
2020;10(8):a038778. responses. Viruses. 2012;4(9):1438-1476.
doi: 10.1101/cshperspect.a038778 doi: 10.3390/v4091438
144. Wu NC, Wilson IA. A perspective on the structural and 153. Nuwarda RF, Alharbi AA, Kayser V. An overview of influenza
functional constraints for immune evasion: Insights from viruses and vaccines. Vaccines (Basel). 2021;9(9):1032.
influenza virus. J Mol Biol. 2017;429(17):2694-2709. doi: 10.3390/vaccines9091032
doi: 10.1016/j.jmb.2017.06.015 154. Santiago GA, Volkman HR, Flores B, et al. SARS-CoV-2
145. Faraji N, Zeinali T, Joukar F, et al. Mutational dynamics omicron replacement of delta as predominant variant,
of SARS-CoV-2: Impact on future COVID-19 vaccine Puerto Rico. Emerg Infect Dis. 2023;29(4):855-857.
strategies. Heliyon. 2024;10(9):e30208. doi: 10.3201/eid2904.221700
doi: 10.1016/j.heliyon.2024.e30208 155. Zhao H, Han K, Gao C, et al. VOC-alarm: Mutation-
based prediction of SARS-CoV-2 variants of concern.
146. Ma KC, Shirk P, Lambrou AS, et al. Genomic surveillance Bioinformatics. 2022;38(14):3549-3556.
for SARS-CoV-2 variants: circulation of omicron
lineages - United States, January 2022-May 2023. MMWR doi: 10.1093/bioinformatics/btac370
Morb Mortal Wkly Rep. 2023;72(24):651-656. 156. Salehi-Vaziri M, Fazlalipour M, Seyed Khorrami SM,
doi: 10.15585/mmwr.mm7224a2 et al. The ins and outs of SARS-CoV-2 variants of concern
(VOCs). Arch Virol. 2022;167(2):327-344.
147. Ma KC, Castro J, Lambrou AS, et al. Genomic surveillance
for SARS-CoV-2 variants: Circulation of omicron XBB and doi: 10.1007/s00705-022-05365-2
JN.1 lineages - United States, May 2023-September 2024. 157. Tegally H, Wilkinson E, Tsui JL, et al. Dispersal patterns and
MMWR Morb Mortal Wkly Rep. 2024;73(42):938-945. influence of air travel during the global expansion of SARS-CoV-2
doi: 10.15585/mmwr.mm7342a1 variants of concern. Cell. 2023;186(15):3277-3290.e16.
148. Grabowski F, Preibisch G, Giziński S, Kochańczyk M, doi: 10.1016/j.cell.2023.06.001
Lipniacki T. SARS-CoV-2 variant of concern 202012/01 has 158. Chen S, Guo L, Xie Y, et al. Government responses
about twofold replicative advantage and acquires concerning to the COVID-19 pandemic of the Gulf Cooperation
mutations. Viruses. 2021;13(3):392. Council countries: Good practices and lessons for future
doi: 10.3390/v13030392 preparedness. Glob Health Res Policy. 2024;9(1):10.
149. Havasi A, Visan S, Cainap C, Cainap SS, Mihaila AA, doi: 10.1186/s41256-024-00349-y
Pop LA. Influenza A, influenza B, and SARS-CoV-2 159. Kisa S, Kisa A. A comprehensive analysis of COVID-19
similarities and differences - a focus on diagnosis. Front misinformation, public health impacts, and communication
Microbiol. 2022;13:908525. strategies: Scoping review. J Med Intern Res. 2024;26:e56931.
doi: 10.3389/fmicb.2022.908525 doi: 10.2196/56931

Volume 2 Issue 3 (2025) 107 doi: 10.36922/MI025190042